statistiche ricercatore

Continente	#
NA - Nord America	454
EU - Europa	394
AS - Asia	282
SA - Sud America	74
AF - Africa	32
Continente sconosciuto - Info sul continente non disponibili	30
OC - Oceania	2
Totale	1.268

Nome	#
1621P miRNA signature as early predictor of hyponatremia and survival in lung cancer: Preliminary results from the ISA retrospective study	195
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors	181
The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy	141
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)	138
BRCA mutations and gastrointestinal cancers: When to expect the unexpected?	136
NSCLC-Pro ClustAI: A Machine Learning Model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors	134
miRNA signature as early predictor of hyponatremia and survival in lung cancer: preliminary results from the ISA retrospective study	130
Studio e ricerca di biomarcatori correlati con l’iponatriemia nei pazienti con tumore al polmone: genotipizzazione dei polimorfismi a singolo nucleotide ed analisi di espressione dei microRNA e dei recettori della vasopressina.	107
Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine	91
Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High‐Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale	15
Totale	1.268

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	6	0	0	0	0	0	0	0	0	4	1	0	1
2022/2023	18	1	3	1	1	3	3	0	0	4	0	2	0
2023/2024	78	2	0	0	1	6	2	0	0	0	0	1	66
2024/2025	358	20	15	55	16	28	10	22	15	61	40	25	51
2025/2026	769	71	91	114	82	48	51	107	58	30	55	31	31
2026/2027	39	22	17	0	0	0	0	0	0	0	0	0	0
Totale													1.268